Leukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency

Andreas Ohlenbusch1, Simon Edvardson, Johannes Skorpen

  • 1Department of Pediatrics and Pediatric Neurology, Georg August University, Robert Koch Str, 40, Göttingen, 37075, Germany. aohlenb@gwdg.de

Abstract

Insights

Mutations in the SDHAF1 gene cause complex II deficiency, leading to infantile leukoencephalopathy with succinate accumulation. This finding links SDHAF1 mutations to a specific mitochondrial disease presentation.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Complex II (succinate dehydrogenase, SDH) deficiency is a rare mitochondrial disorder with varied symptoms.
  • SDHAF1 gene mutations have been linked to SDH-defective infantile leukoencephalopathy.
  • The clinical spectrum and genetic basis of SDH deficiency require further elucidation.

Purpose of the Study:

  • To identify SDHAF1 mutations in patients with complex II deficiency.
  • To define the clinical phenotype associated with SDHAF1 mutations.
  • To investigate the role of SDHAF1 in mitochondrial complex assembly.

Main Methods:

  • Retrospective analysis of nine children with biochemically confirmed complex II deficiency.
  • Genetic sequencing of the SDHAF1 gene in all patients.
  • In vivo proton MR spectroscopy to detect succinate accumulation in cerebral white matter.

Main Results:

  • Homozygous SDHAF1 mutations were found in five patients with leukoencephalopathy and succinate accumulation.
  • No SDHAF1 mutations were detected in four patients with diverse clinical phenotypes.
  • Two known and two novel SDHAF1 mutations were identified.

Conclusions:

  • SDHAF1 mutations are a significant cause of complex II assembly defects.
  • Leukoencephalopathy with succinate accumulation is a key clinical feature of SDHAF1-related mitochondrial disease.
  • Genetic testing of SDHAF1 is crucial for diagnosing this specific form of mitochondrial disorder.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
The Supercomplexes in the Crista Membrane01:41

The Supercomplexes in the Crista Membrane

The mitochondrial cristae membrane is the primary site for the oxidative phosphorylation (OXPHOS) process of energy conversion mediated through respiratory complexes I to V. These complexes have been widely studied for decades, and it has been proven that they form supramolecular structures called respiratory supercomplexes (SC). These higher-order complexes may be crucial in maintaining the biochemical structure and improving the physiological activity of the individual complexes while...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...